Contact
Please use this form to send email to PR contact of this press release:
Global Blood Therapeutics Announces Enrollment of First Patient in Phase 3 HOPE Study in Sickle Cell Disease
TO:
Please use this form to send email to PR contact of this press release:
Global Blood Therapeutics Announces Enrollment of First Patient in Phase 3 HOPE Study in Sickle Cell Disease
TO: